Subscribe To
BlueSphere Bio Appoints Erkut Bahceci, M.D., as Chief Medical Officer
Dr. Bahceci brings more than two decades of combined clinical and drug development experience PITTSBURGH, Pa., Jan. 30, 2023 (GLOBE NEWSWIRE) — BlueSphere Bio, a T-cell receptor (TCR) T-cell therapy company developing a powerful TCR discovery platform and novel therapeutic candidates for patients with hematologic malignancies and solid tumors, today announced the appointment of Erkut […] The post BlueSphere Bio Appoints Erkut Bahceci, M.D., as Chief Medical Officer appeared first on ForexTV...
Read More
Posted: Jan 30 2023, 15:17
Author Name: forextv
Views: 103061